On Thursday, July 12, the ALS community will have the opportunity to meet with representatives from the FDA and the pharmaceutical industry during an ALS Community Workshop in order to discuss the latest FDA guidance document related to ALS drug development.
Both in-person and online attendees will be able to ask questions and comment. Continue reading for instructions on submitting questions and comments that may be addressed during the Workshop.
If you plan on attending the (online) live stream event, please register here: https://thealsassociation.formstack.com/forms/signup.
The ALS Association will accept questions and comments from in-person and online Workshop attendees. We encourage online attendees to submit questions in advance and during the live event by sending email messages to our designated Workshop email inbox: ALSFDAworkshop@alsa-national.org.
The ALS Association will review all questions and then elevate questions to the Workshop moderator.
While we may not be able to answer every question submitted, our priority is to make sure every voice is heard. You can ensure your voice is heard by participating in the conversation on social media using the hashtag #ALSFDA.
Two weeks after the Workshop, we will compile any additional questions and comments from the ALS community and send them all to FDA leadership.
The ALS Association invites attendees to submit questions and comments by email prior to and during the Workshop. Please note that emailed questions will take top priority.
We look forward to an engaging and informative conversation with the ALS community on July 12.
For more information about the Workshop, click here.